Parenteral Nutrition Market to reach USD 12.6 billion by 2033, Amino acids dominate 28% market share | key Players- Sichuan Kelun Pharmaceutical Co., Ltd., Allergan plc.

The Parenteral Nutrition Market is estimated to be valued at USD 6.5 billion in 2025 and is projected to reach USD 12.6 billion by 2033, registering a compound annual growth rate (CAGR) of 6.5% over the forecast period.

The Parenteral Nutrition Market is growing due to rising prevalence of chronic diseases, increasing geriatric population, advancements in PN formulations, greater hospital and home healthcare adoption, and awareness of malnutrition management, driving higher demand for intravenous nutritional support globally.

Download your exclusive free sample report today: (corporate email gets priority access):https://www.datamintelligence.com/download-sample/parenteral-nutrition-market?pratik

Japan: Key Industry Developments:-
✅ October 2025: Otsuka Pharmaceutical launched a new line of carbohydrate-dominant parenteral nutrition solutions approved by PMDA, optimized for post-surgical recovery with reduced glucose intolerance risks.

✅ September 2025: Terumo Corporation rolled out ready-to-use parenteral nutrition bags with balanced electrolytes and vitamins, targeting elderly patients amid Japan's aging population trends.

✅ August 2025: The Japanese health ministry boosted subsidies for local parenteral nutrition innovations, spurring developments in biotech-enhanced formulations for chronic disease management

United States: Key Industry Developments:-
✅ November 2025: Fresenius Kabi expanded its parenteral nutrition portfolio with FDA-approved single-dose bags featuring enhanced lipid emulsions for better stability in critically ill patients, reducing contamination risks during hospital administration.

✅ October 2025: Baxter International launched a customized total parenteral nutrition (TPN) formulation tailored for oncology patients, incorporating advanced amino acid profiles to address malnutrition from chemotherapy side effects.

✅ September 2025: B. Braun introduced AI-monitored compounding systems for parenteral nutrition in U.S. hospitals, improving precision in multi-chamber bag preparation and supporting regulatory compliance for safety

2025 M&A Activity:-
Fresenius Kabi acquired the parenteral nutrition assets of Nipro Medical in March 2025, expanding its product portfolio and manufacturing footprint across Europe and Asia for clinical nutrition and parenteral solutions, reinforcing its leadership in the global parenteral nutrition segment.

Baxter International completed the acquisition of Paragon BioTeck's sterile injectables portfolio in June 2025 to broaden its parenteral nutrition admixture offerings and enhance manufacturing capacity, strengthening Baxter's sterile nutrition solutions business globally.

Preferred Excellent Care was acquired by AIS HealthCare on August 21, 2025, broadening the acquirer's home infusion services that include total parenteral nutrition (TPN) delivery, thereby increasing service coverage and integrated nutrition therapy offerings.

Danforth Advisors, via financial sponsors including Avesi Partners, acquired Preferred Excellent Care on August 25, 2025, supporting expanded home infusion and specialized intravenous nutrition services delivery, which includes parenteral nutrition therapies in the U.S. home care market.

H.I.G. Capital completed the acquisition of ITH Group Limited, including ITH Pharma's compounding and intravenous treatment operations, on June 9, 2025, enhancing capabilities in complex parenteral therapies and infusion compounding relevant to nutritional support services.

Report Objectives

The global Parenteral Nutrition Market report delivers a detailed analysis with 70 key tables, more than 66 visually impactful figures, and 147 pages of expert insights, providing a complete view of the market landscape.

"Secure your 30% year-end discount - get this report before the offer expires.":https://www.datamintelligence.com/buy-now-page?report=parenteral-nutrition-market?pratik ((Purchase 2 or more Repots and get 50% Discount)

Market Segmenatation-

By Nutrient Type
Amino acids: 28%, USD 1.7B - Key for protein synthesis in patients unable to absorb oral nutrition.
Parenteral lipid emulsions: 25%, USD 1.8B - High-calorie energy source preventing fatty acid deficiencies.
Electrolytes & minerals: 16%, USD 1.2B - Correct imbalances in surgical or chronic cases.
Vitamins: 11%, USD 0.8B - Support immune and metabolic functions.
Trace elements: 10%, USD 0.7B - Essential micronutrient supplementation.
Others: 10%, USD 0.7B - Includes fats and additional nutrients.

By End User
Hospitals: 55%, USD 4.1B - High ICU and surgical usage.
Clinics: 17%, USD 1.3B - Outpatient procedures.
Homecare: 23%, USD 1.7B - Growing due to aging populations and home infusion.
Others: 5%, USD 0.4B - Specialty facilities.

Regional Market Shares (2025)
North America holds the largest share at approximately 38%, driven by product launches, R&D investments, and reimbursement policies.​

Asia Pacific accounts for around 20% currently, with fastest growth expected from urbanization, aging populations, and healthcare expansions in China and India.​

Europe captures a significant portion (estimated 25% based on trends), supported by strong clinical nutrition adoption, though exact 2025 figures are less specified across sources.

Get Customization in the report as per your requirements:https://www.datamintelligence.com/customize/parenteral-nutrition-market?pratik

Market Players:-

Major players are Sichuan Kelun Pharmaceutical Co., Ltd., Allergan plc (Actavis plc), Fresenius Kabi AG, Grifols S.A., Baxter International, Inc., Claris Lifesciences Limited, B. Braun Melsungen AG and Pfizer, Inc.

Top 3 Players
Top Player: Baxter International, Inc.
Baxter holds the dominant position with an estimated 26% market share, driven by its extensive portfolio of parenteral nutrition components, ready-to-use multi-chamber bags, and strong global hospital partnerships. The company invests heavily in sterile manufacturing and clinical education, reinforcing leadership in North America and Europe.​

Second Player: Fresenius Kabi AG
Fresenius Kabi commands 22% of the market, specializing in customizable parenteral nutrition solutions for adults and pediatrics, including glucose-based products with enhanced stability. Its global distribution and expansion into emerging markets bolster its clinical nutrition footprint.​

Third Player: B. Braun Melsungen AG
B. Braun secures 15% share through competitive offerings in carbohydrate and lipid emulsions, focusing on patient-specific formulations. The firm excels in therapeutic nutrition for critical care, supported by innovations in infusion therapies.

Key Market Drivers for Parenteral Nutrition:-
Rising Prevalence of Malnutrition and Chronic Diseases

Increasing rates of malnutrition, especially among hospitalized patients and the elderly, drive the demand for PN solutions.

Chronic illnesses such as cancer, gastrointestinal disorders, and liver or kidney diseases often require PN for adequate nutrition when oral or enteral feeding is not possible.

Growing Geriatric Population

Older adults are more prone to malnutrition and hospitalization, which increases the requirement for PN therapy.

The aging population globally is creating a steady demand for advanced nutritional support.

Advancements in PN Formulations

Development of specialized and customized PN formulations (e.g., amino acid solutions, lipid emulsions, electrolyte-balanced formulations) improves patient outcomes.

These innovations are making PN safer, more efficient, and widely applicable across different patient groups.

Increase in Surgical Procedures and Critical Care Needs

Rising numbers of surgeries and critical care interventions (ICU admissions, trauma care) often necessitate PN when patients cannot consume food orally.

Post-operative recovery and critically ill patients heavily rely on PN to meet nutritional requirements.

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?pratik
✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About DataM Intelligence
DataM Intelligence is a renowned provider of market research, delivering deep insightsthrough pricing analysis, market share breakdowns, and competitive intelligence. Thecompany specializes in strategic reports that guide businesses in high-growth sectors suchas nutraceuticals and AI-driven health innovations.
To find out more, visit https://www.datamintelligence.com/ or follow us on Twitter,LinkedIn and Facebook.

This release was published on openPR.